A citation-based method for searching scientific literature

Silvia Arpicco, Paola Milla, Barbara Stella, Franco Dosio. Molecules 2014
Times Cited: 72







List of co-cited articles
572 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine.
George Mattheolabakis, Lara Milane, Amit Singh, Mansoor M Amiji. J Drug Target 2015
246
15

Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors.
Shanthi Ganesh, Arun K Iyer, David V Morrissey, Mansoor M Amiji. Biomaterials 2013
224
13

Hyaluronic acid for anticancer drug and nucleic acid delivery.
Franco Dosio, Silvia Arpicco, Barbara Stella, Elias Fattal. Adv Drug Deliv Rev 2016
295
13

Hyaluronic acid based scaffolds for tissue engineering--a review.
Maurice N Collins, Colin Birkinshaw. Carbohydr Polym 2013
508
11

Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.
Ki Young Choi, Gurusamy Saravanakumar, Jae Hyung Park, Kinam Park. Colloids Surf B Biointerfaces 2012
158
11

Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response.
Shoshy Mizrahy, Sabina Rebe Raz, Martin Hasgaard, Hong Liu, Neta Soffer-Tsur, Keren Cohen, Ram Dvash, Dalit Landsman-Milo, Maria G E G Bremer, S Moein Moghimi,[...]. J Control Release 2011
168
11

Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Xiongwei Deng, Minjun Cao, Jiakun Zhang, Kelei Hu, Zhaoxia Yin, Zhixiang Zhou, Xiangqian Xiao, Yishu Yang, Wang Sheng, Yan Wu,[...]. Biomaterials 2014
302
9


Hyaluronan-CD44 interactions as potential targets for cancer therapy.
Suniti Misra, Paraskevi Heldin, Vincent C Hascall, Nikos K Karamanos, Spyros S Skandalis, Roger R Markwald, Shibnath Ghatak. FEBS J 2011
331
9


Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin.
Hyun-Jong Cho, In-Soo Yoon, Hong Yeol Yoon, Heebeom Koo, Yu-Jin Jin, Seung-Hak Ko, Jae-Seong Shim, Kwangmeyung Kim, Ick Chan Kwon, Dae-Duk Kim. Biomaterials 2012
172
9

In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles.
Shanthi Ganesh, Arun K Iyer, Florence Gattacceca, David V Morrissey, Mansoor M Amiji. J Control Release 2013
101
9

Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.
Nicolas Bertrand, Jun Wu, Xiaoyang Xu, Nazila Kamaly, Omid C Farokhzad. Adv Drug Deliv Rev 2014
9

Self-assembled hyaluronic acid nanoparticles for active tumor targeting.
Ki Young Choi, Hyunjin Chung, Kyung Hyun Min, Hong Yeol Yoon, Kwangmeyung Kim, Jae Hyung Park, Ick Chan Kwon, Seo Young Jeong. Biomaterials 2010
349
9

Hyaluronic acid-coated liposomes for active targeting of gemcitabine.
Silvia Arpicco, Carlotta Lerda, Elisa Dalla Pozza, Chiara Costanzo, Nicolas Tsapis, Barbara Stella, Massimo Donadelli, Ilaria Dando, Elias Fattal, Luigi Cattel,[...]. Eur J Pharm Biopharm 2013
96
9

Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
Yanhua Liu, Jin Sun, Wen Cao, Jianhong Yang, He Lian, Xin Li, Yinghua Sun, Yongjun Wang, Siling Wang, Zhonggui He. Int J Pharm 2011
138
9

Tailored doxorubicin-hyaluronan conjugate as a potent anticancer glyco-drug: an alternative to prodrug approach.
Oommen P Oommen, Javad Garousi, Marije Sloff, Oommen P Varghese. Macromol Biosci 2014
46
13

Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging.
Jingchao Li, Yao He, Wenjie Sun, Yu Luo, Hongdong Cai, Yunqi Pan, Mingwu Shen, Jindong Xia, Xiangyang Shi. Biomaterials 2014
143
8

Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate.
Min Sang Lee, Jung Eun Lee, Eunkyoung Byun, Nak Won Kim, Kyuri Lee, Haeshin Lee, Sang Jun Sim, Doo Sung Lee, Ji Hoon Jeong. J Control Release 2014
87
8

Nanocarriers as an emerging platform for cancer therapy.
Dan Peer, Jeffrey M Karp, Seungpyo Hong, Omid C Farokhzad, Rimona Margalit, Robert Langer. Nat Nanotechnol 2007
8


Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel.
Jing Li, Meirong Huo, Jing Wang, Jianping Zhou, Jumah M Mohammad, Yinlong Zhang, Qinnv Zhu, Ayman Y Waddad, Qiang Zhang. Biomaterials 2012
273
8

Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.
Maria de la Fuente, Begoña Seijo, Maria J Alonso. Invest Ophthalmol Vis Sci 2008
168
8

Hyaluronan fragments: an information-rich system.
Robert Stern, Akira A Asari, Kazuki N Sugahara. Eur J Cell Biol 2006
742
6

Hyaluronic acid-based conjugates for tumor-targeted drug delivery and imaging.
Gurusamy Saravanakumar, V G Deepagan, R Jayakumar, Jae Hyung Park. J Biomed Nanotechnol 2014
31
16

Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticles.
Shoshy Mizrahy, Meir Goldsmith, Shani Leviatan-Ben-Arye, Einat Kisin-Finfer, Orit Redy, Srimeenakshi Srinivasan, Doron Shabat, Biana Godin, Dan Peer. Nanoscale 2014
44
11

Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel.
Hyun-Jong Cho, Hong Yeol Yoon, Heebeom Koo, Seung-Hak Ko, Jae-Seong Shim, Ju-Hee Lee, Kwangmeyung Kim, Ick Chan Kwon, Dae-Duk Kim. Biomaterials 2011
219
6

Hyaluronan.
T C Laurent, J R Fraser. FASEB J 1992
6

Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells.
Silvia Arpicco, Giuseppe De Rosa, Elias Fattal. J Drug Deliv 2013
44
11

Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
Xiaopeng Han, Zhenbao Li, Jin Sun, Cong Luo, Lin Li, Yuhai Liu, Yuqian Du, Shuhong Qiu, Xiaoyu Ai, Chunnuan Wu,[...]. J Control Release 2015
105
6

Impact of nanotechnology on drug delivery.
Omid C Farokhzad, Robert Langer. ACS Nano 2009
6

Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives.
Eun Ju Oh, Kitae Park, Ki Su Kim, Jiseok Kim, Jeong-A Yang, Ji-Hyun Kong, Min Young Lee, Allan S Hoffman, Sei Kwang Hahn. J Control Release 2010
342
6


Nanoparticle therapeutics: an emerging treatment modality for cancer.
Mark E Davis, Zhuo Georgia Chen, Dong M Shin. Nat Rev Drug Discov 2008
6

Hyaluronic acid and its derivatives in drug delivery and imaging: Recent advances and challenges.
Giuseppe Tripodo, Adriana Trapani, Maria Luisa Torre, Gaetano Giammona, Giuseppe Trapani, Delia Mandracchia. Eur J Pharm Biopharm 2015
117
6

Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.
Meihua Yu, Siddharth Jambhrunkar, Peter Thorn, Jiezhong Chen, Wenyi Gu, Chengzhong Yu. Nanoscale 2013
189
6

Potential therapeutic application of chondroitin sulfate/dermatan sulfate.
Shuhei Yamada, Kazuyuki Sugahara. Curr Drug Discov Technol 2008
143
5

Biodegradable polymeric nanoparticles based drug delivery systems.
Avnesh Kumari, Sudesh Kumar Yadav, Subhash C Yadav. Colloids Surf B Biointerfaces 2010
5

Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties.
N Itano, T Sawai, M Yoshida, P Lenas, Y Yamada, M Imagawa, T Shinomura, M Hamaguchi, Y Yoshida, Y Ohnuki,[...]. J Biol Chem 1999
654
5


A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells.
Y Luo, M R Ziebell, G D Prestwich. Biomacromolecules 2000
176
5

Paclitaxel-hyaluronic nanoconjugates prolong overall survival in a preclinical brain metastases of breast cancer model.
Rajendar K Mittapalli, Xinli Liu, Chris E Adkins, Mohamed I Nounou, Kaci A Bohn, Tori B Terrell, Hussaini S Qhattal, Werner J Geldenhuys, Diane Palmieri, Patricia S Steeg,[...]. Mol Cancer Ther 2013
56
7



Biodegradable self-assembled nanoparticles of poly (D,L-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer.
Jingbin Huang, He Zhang, Yuan Yu, Yan Chen, Dong Wang, Guoqing Zhang, Guichen Zhou, Junjie Liu, Zhiguo Sun, Duxin Sun,[...]. Biomaterials 2014
129
5

HYTAD1-p20: a new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer.
Antonio Rosato, Alessandra Banzato, Gilda De Luca, Davide Renier, Fabio Bettella, Claudio Pagano, Giovanni Esposito, Paola Zanovello, PierFrancesco Bassi. Urol Oncol 2006
64
6

A paclitaxel-hyaluronan bioconjugate targeting ovarian cancer affords a potent in vivo therapeutic activity.
Alessandra Banzato, Sara Bobisse, Maria Rondina, Davide Renier, Fabio Bettella, Giovanni Esposito, Luigi Quintieri, Laura Meléndez-Alafort, Ulderico Mazzi, Paola Zanovello,[...]. Clin Cancer Res 2008
76
5


Bimodal tumor-targeting from microenvironment responsive hyaluronan layer-by-layer (LbL) nanoparticles.
Erik C Dreaden, Stephen W Morton, Kevin E Shopsowitz, Jae-Hyeok Choi, Zhou J Deng, Nam-Joon Cho, Paula T Hammond. ACS Nano 2014
111
5



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.